Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study

Lancet. 2002 Jun 22;359(9324):2200-1; author reply 2203-4. doi: 10.1016/S0140-6736(02)09071-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects
  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Atenolol / adverse effects
  • Atenolol / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Humans
  • Losartan / adverse effects
  • Losartan / therapeutic use*
  • Male
  • Middle Aged
  • Randomized Controlled Trials as Topic

Substances

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Atenolol
  • Losartan